April K.S. Salama

Also affiliated with Duke Medical Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “A multicenter characterization of hepatitis associated with immune checkpoint inhibitors”.

A multicenter characterization of hepatitis associated with immune checkpoint inhibitors

OncoImmunology(2021)10.1080/2162402x.2021.1875639

N/A

2.2DataRank · unranked

63 citations

Ben McGuigan, Sunandana Chandra, Sarah E. Fenton, Akansha Chowdhary, Lucy Boyce Kennedy +14 more

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002203

N/A

1.8DataRank · unranked

80 citations

Smita K. Nair, Norma E. Farrow, Karenia Landa, Maria Angelica Selim, Carol Ann Wiggs +6 more

Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005052

N/A

0.703DataRank · unranked

42 citations

Michael C. Brown, Norma E. Farrow, Karenia Landa, Rami N. Al‐Rohil, Maria Angelica Selim +10 more

Randomized phase II trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with BRAF-mutant (MT) metastatic melanoma (MM) (CTEP P9466).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9511

N/A

0.239DataRank · unranked

3 citations

Janice M. Mehnert, Anita Giobbie‐Hurder, Kari Kendra, Gino K. In, April K.S. Salama +14 more

A Need for More Molecular Profiling in Brain Metastases

Frontiers in Oncology(2022)10.3389/fonc.2021.785064

N/A

0DataRank · unranked

7 citations

Amanda E.D. Van Swearingen, Meghan Price, Ketan R. Bulsara, Roeland Verhaak, César Baëta +9 more

Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases

npj Precision Oncology(2023)10.1038/s41698-023-00471-z

N/A

0DataRank · unranked

24 citations

Jennifer R. Ribeiro, Jun Yin, Joanne Xiu, Matías A. Bustos, Fumito Ito +17 more

Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain Metastases

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.12.002

N/A

0DataRank · unranked

18 citations

R.F. Shenker, Peter G. Hendrickson, Zihan Wan, Donna Niedzwiecki, Sebastian Winter +12 more

Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?

Annals of Surgical Oncology(2023)10.1245/s10434-023-13935-0

N/A

0DataRank · unranked

9 citations

Sin‐Ho Jung, Kelly M. Elleson, Danielle K. DePalo, Richard J. Straker, Sophia K. McKinley +11 more

Atopy improves survival and decreases risk of brain metastasis in cutaneous melanoma

medRxiv(2024)10.1101/2024.05.15.24307061

N/A

0DataRank · unranked

0 citations

Mackenzie Price, Gino Cioffi, Zhen Liu, Rabina Walsh, Jill S. Barnholtz‐Sloan +6 more

Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain Metastases

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.4347

N/A

0DataRank · unranked

19 citations

R.F. Shenker, Peter G. Hendrickson, Zihan Wan, Donna Niedzwiecki, David Carpenter +14 more

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy

Journal of Clinical Investigation(2020)10.1172/jci133055

N/A

0DataRank · unranked

251 citations

Kathy S. Evans, Nicholas C. DeVito, Michael P. Plebanek, Michael Sturdivant, Luke P. Wachsmuth +10 more

Management outcomes for biopsy-proven radiation necrosis in patients with brain metastases in the era of immune-checkpoint blockade

Journal of Neuro-Oncology(2025)10.1007/s11060-025-05120-y

N/A

0DataRank · unranked

1 citations

Laura Alder, April K.S. Salama, Carey K. Anders, Jordan Komisarow, Peter E. Fecci +7 more

Advanced Melanoma

Hematology/Oncology Clinics of North America(2020)10.1016/j.hoc.2020.09.005

N/A

0DataRank · unranked

16 citations

April K.S. Salama, Douglas B. Johnson, Alexandra M. Haugh

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

Cell Reports(2021)10.1016/j.celrep.2021.109071

N/A

0DataRank · unranked

82 citations

Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K.S. Salama +6 more

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy

Science Translational Medicine(2022)10.1126/scitranslmed.abq7019

N/A

0DataRank · unranked

55 citations

Nagendra Yarla, Tarek Haykal, Y‐Van Nguyen, Linda Cao, Michelle Ferreira +8 more